Barclays’s LifeVantage LFVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263K | Buy |
60,914
+12,663
| +26% | +$66.3K | ﹤0.01% | 3537 |
|
|
2025
Q4 | $297K | Buy |
48,251
+12,883
| +36% | +$95.4K | ﹤0.01% | 4130 |
|
|
2025
Q3 | $344K | Buy |
35,368
+4,694
| +15% | +$58.8K | ﹤0.01% | 4014 |
|
|
2025
Q2 | $401K | Buy |
30,674
+3,054
| +11% | +$39.5K | ﹤0.01% | 3887 |
|
|
2025
Q1 | $403K | Sell |
27,620
-15,852
| -36% | -$299K | ﹤0.01% | 3651 |
|
|
2024
Q4 | $762K | Buy |
43,472
+1,506
| +4% | +$21.1K | ﹤0.01% | 3561 |
|
|
2024
Q3 | $507K | Buy |
41,966
+11,608
| +38% | +$96.1K | ﹤0.01% | 3767 |
|
|
2024
Q2 | $195K | Hold |
30,358
| – | – | ﹤0.01% | 3592 |
|
|
2024
Q1 | $184K | Hold |
30,358
| – | – | ﹤0.01% | 4160 |
|
|
2023
Q4 | $182K | Hold |
30,358
| – | – | ﹤0.01% | 4458 |
|
|
2023
Q3 | $196K | Hold |
30,358
| – | – | ﹤0.01% | 3312 |
|
|
2023
Q2 | $132K | Hold |
30,358
| – | – | ﹤0.01% | 3446 |
|
|
2023
Q1 | $109K | Hold |
30,358
| – | – | ﹤0.01% | 4126 |
|
|
2022
Q4 | $113K | Hold |
30,358
| – | – | ﹤0.01% | 4156 |
|
|
2022
Q3 | $114K | Sell |
30,358
-1,654
| -5% | -$6.69K | ﹤0.01% | 3487 |
|
|
2022
Q2 | $139K | Sell |
32,012
-744
| -2% | -$3.25K | ﹤0.01% | 3619 |
|
|
2022
Q1 | $156K | Hold |
32,756
| – | – | ﹤0.01% | 3569 |
|
|
2021
Q4 | $207K | Sell |
32,756
-1,709
| -5% | -$11.6K | ﹤0.01% | 3555 |
|
|
2021
Q3 | $234K | Sell |
34,465
-3,492
| -9% | -$25.7K | ﹤0.01% | 3536 |
|
|
2021
Q2 | $279K | Buy |
37,957
+14,308
| +61% | +$117K | ﹤0.01% | 3401 |
|
|
2021
Q1 | $221K | Buy |
23,649
+19,226
| +435% | +$179K | ﹤0.01% | 3660 |
|
|
2020
Q4 | $42K | Sell |
4,423
-1,795
| -29% | -$20.2K | ﹤0.01% | 4483 |
|
|
2020
Q3 | $75K | Sell |
6,218
-1,251
| -17% | -$16.9K | ﹤0.01% | 4394 |
|
|
2020
Q2 | $101K | Buy |
7,469
+2,662
| +55% | +$36.9K | ﹤0.01% | 4508 |
|
|
2020
Q1 | $50K | Sell |
4,807
-9,344
| -66% | -$128K | ﹤0.01% | 5233 |
|
|
2019
Q4 | $221K | Buy |
14,151
+7,234
| +105% | +$106K | ﹤0.01% | 4958 |
|
|
2019
Q3 | $95K | Sell |
6,917
-4,768
| -41% | -$58.1K | ﹤0.01% | 5513 |
|
|
2019
Q2 | $152K | Sell |
11,685
-75,749
| -87% | -$900K | ﹤0.01% | 5350 |
|
|
2019
Q1 | $1.25M | Buy |
87,434
+26,234
| +43% | +$381K | ﹤0.01% | 3154 |
|
|
2018
Q4 | $807K | Buy |
61,200
+60,168
| +5,830% | +$720K | ﹤0.01% | 3328 |
|
|
2018
Q3 | $11K | Buy |
+1,032
| New | +$11K | ﹤0.01% | 6633 |
|
|
2017
Q3 | – | Sell |
-25,231
| Closed | -$109K | – | 6953 |
|
|
2017
Q2 | $109K | Buy |
25,231
+18,066
| +252% | +$79.7K | ﹤0.01% | 4837 |
|
|
2017
Q1 | $38K | Sell |
7,165
-10,959
| -60% | -$69.2K | ﹤0.01% | 5484 |
|
|
2016
Q4 | $148K | Sell |
18,124
-16,739
| -48% | -$143K | ﹤0.01% | 4454 |
|
|
2016
Q3 | $330K | Buy |
34,863
+163
| +0.5% | +$2.12K | ﹤0.01% | 3572 |
|
|
2016
Q2 | $472K | Sell |
34,700
-2,800
| -7% | -$31.8K | ﹤0.01% | 3269 |
|
|
2016
Q1 | $338K | Buy |
37,500
+18,100
| +93% | +$161K | ﹤0.01% | 3459 |
|
|
2015
Q4 | $175K | Buy |
+19,400
| New | +$146K | ﹤0.01% | 4012 |
|
|
2014
Q4 | – | Sell |
-1,089
| Closed | -$8K | – | 7451 |
|
|
2014
Q3 | $8K | Sell |
1,089
-6,373
| -85% | -$58.4K | ﹤0.01% | 6984 |
|
|
2014
Q2 | $52K | Buy |
7,462
+2,979
| +66% | +$28.3K | ﹤0.01% | 5909 |
|
|
2014
Q1 | $31K | Sell |
4,483
-813
| -15% | -$8.15K | ﹤0.01% | 6348 |
|
|
2013
Q4 | $37K | Buy |
5,296
+2,584
| +95% | +$36.4K | ﹤0.01% | 6387 |
|
|
2013
Q3 | $38K | Buy |
2,712
+1,861
| +219% | +$32.1K | ﹤0.01% | 6209 |
|
|
2013
Q2 | $14K | Buy |
+851
| New | +$13.7K | ﹤0.01% | 6987 |
|
Other funds holding LFVN
CM
VCM
Barclays's LFVN Position: Q1 2026 in Review
Barclays increased its LifeVantage (LFVN) stake by 26% in Q1 2026, buying an estimated $66.3K and bringing the position to 60,914 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #3537.
Barclays first reported a position in LFVN in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.25M in Q1 2019. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.
- Barclays held 60,914 shares of LifeVantage worth $263K as of Q1 2026.
- Barclays bought 12,663 LifeVantage shares in Q1 2026, an estimated $66.3K.
- LifeVantage made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3537 holding.
- Barclays first reported a position in LifeVantage in Q2 2013 and has held it in 44 quarters since.
- Barclays's LifeVantage position peaked at $1.25M in Q1 2019.
- 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.